BARCHIESI, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 526
EU - Europa 348
AS - Asia 122
SA - Sud America 6
AF - Africa 2
Totale 1.004
Nazione #
US - Stati Uniti d'America 521
IT - Italia 207
SG - Singapore 63
SE - Svezia 60
IN - India 26
DE - Germania 21
GB - Regno Unito 18
FI - Finlandia 16
CN - Cina 14
ID - Indonesia 12
CA - Canada 4
FR - Francia 4
HK - Hong Kong 4
BG - Bulgaria 3
EE - Estonia 3
IE - Irlanda 3
IR - Iran 3
RO - Romania 3
RU - Federazione Russa 3
UA - Ucraina 3
BR - Brasile 2
CH - Svizzera 2
CL - Cile 2
TG - Togo 2
AR - Argentina 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
NL - Olanda 1
PT - Portogallo 1
Totale 1.004
Città #
Fairfield 87
Rome 54
Woodbridge 49
Singapore 47
Seattle 43
Ashburn 37
Houston 32
Chandler 27
Cambridge 25
Ann Arbor 23
Santa Clara 22
Wilmington 21
Milan 15
San Paolo di Civitate 14
Dearborn 13
Helsinki 11
Jakarta 11
Princeton 11
Florence 10
Lawrence 8
New York 8
Beijing 7
Cappelle sul Tavo 7
Millbury 7
Surrey 7
Bremen 6
Boston 5
Plano 5
Sacramento 5
Hong Kong 4
Naples 4
San Diego 4
Seriate 4
Albenga 3
Bologna 3
Dublin 3
Falkenstein 3
Genoa 3
Glasgow 3
Palermo 3
Sofia 3
Tallinn 3
Vicenza 3
Albignasego 2
Ancona 2
Andover 2
Bagheria 2
Bari 2
Castellanza 2
Dallas 2
Fano 2
Ferrara 2
Forlì 2
Giovinazzo 2
Imola 2
Kunming 2
Lappeenranta 2
Levallois-perret 2
Lomé 2
Moscow 2
Naro 2
Norwalk 2
Ottawa 2
Sinalunga 2
Temuco 2
Torino 2
Toronto 2
Turin 2
Augusta 1
Barletta 1
Bern 1
Birmingham 1
Boardman 1
Bracciano 1
Caserta 1
Chieti 1
Edinburgh 1
Falls Church 1
Federal 1
Fremont 1
Guidonia 1
Heddesbach 1
Hefei 1
Jacksonville 1
Kish 1
La Paz 1
Liverpool 1
Los Angeles 1
Marseille 1
Miami 1
Nanjing 1
Newark 1
Padova 1
Phoenix 1
Piazza Armerina 1
Poggiomarino 1
Portici 1
Pune 1
San Giuliano Milanese 1
Schio 1
Totale 745
Nome #
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial 120
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis 118
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 107
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 100
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer 95
Prolactin as a potential negative predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO) 87
Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer 79
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 63
Immunotherapy in HER2-positive breast cancer. state of the art and future perspectives 58
null 49
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 43
Observational multicenter study on the prognostic relevance of coagulation activation in risk assessment and stratification in locally advanced breast cancer. Outline of the arias trial 42
Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments 36
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis 35
Neoadjuvant endocrine therapy in breast cancer. Current knowledge and future perspectives 25
Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab 20
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets 11
Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab 7
Totale 1.095
Categoria #
all - tutte 3.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.473


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020166 0 0 0 0 0 30 29 33 27 30 10 7
2020/202197 16 7 8 8 3 2 1 3 5 38 6 0
2021/2022136 0 3 4 6 22 8 1 12 7 5 40 28
2022/2023183 30 45 17 15 18 11 6 12 19 1 8 1
2023/2024167 4 21 1 8 12 28 5 24 5 16 25 18
2024/2025188 12 27 34 36 56 23 0 0 0 0 0 0
Totale 1.095